You are here
Articles
Posted on Saturday, February 16, 2008 - 1:47pm
02/06/2008
Elias Jabbour; Jorge E Cortes; Hady Ghanem; Susan O'Brien; Hagop M Kantarjian
Abstract
Chronic myeloid leukemia (CML) is characterized by the formation of the Philadelphia chromosome and...
Posted on Wednesday, February 6, 2008 - 7:29pm
From The Medscape Journal of Medicine
Webcast Video EditorialsePatients: Engaging Patients in Their Own Care
Posted 01/25/2008
Daniel Z. Sands, MD, MPH
Posted on Wednesday, February 6, 2008 - 7:17pm
New Therapeutic Options in CML and What They Mean for Patients:
An Expert Interview With Dr. Jorge Cortes
Posted on Monday, January 21, 2008 - 7:29pm
BMS Press Release:
Uxbridge, UK. January 21, 2008:
Posted on Friday, January 18, 2008 - 12:28pm
Summary:
Imatinib, or Glivec (Gleevec-USA), is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as...
Posted on Thursday, January 17, 2008 - 7:26pm
The study findings strengthen the hypothesis that domestic use of pesticides may play a role in the etiology of childhood hematopoietic malignancies. The consistency of the findings with those of previous studies on AL...
Posted on Tuesday, January 8, 2008 - 12:52pm
ChemGenex Investigators Report Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients with the T315I Mutation
....more
Posted on Tuesday, January 8, 2008 - 12:32pm
Bosutinib: A New Kinase Inhibitor for Treatment of Philadelphia Chromosome Positive Leukemia
Researchers involved in an international study have reported that bosutinib (SKI606) is a new active kinase inhibitor for the...
Posted on Tuesday, January 8, 2008 - 12:23pm
December 10th 2007
PORTLAND, Ore. - Oregon Health & Science University Cancer Institute researchers have found a new, experimental drug candidate it to be effective against a highly resistant...
Posted on Wednesday, January 2, 2008 - 1:12pm
Report on the 6th CML Patient and Carer Seminar held in Edinburgh on Saturday 24th November 2007
The seminar was held at Houstoun House Hotel which is just outside of Edinburgh and was hosted by Tessa Holyoake from...
Posted on Thursday, November 8, 2007 - 10:05am
Please use this template as a basis (you can change it if you need to) for contacting your MP and making them aware of the situation regarding the proposed NICE appraisal for both Dasatinib and Nilotinib. It is crucial...
Posted on Wednesday, November 7, 2007 - 7:51pm
NCCN 2nd Annual Congress: Hematologic Malignancies - Update on Primary Therapy, Second-Line Therapy, and New Agents for Chronic Myelogenous Leukemia (Slides with Audio) CME/CE
Jerald P. Radich, MD
Posted on Monday, October 8, 2007 - 1:12pm
Please click on the link below to download a list of the centres that are open and recruiting.
Posted on Saturday, September 29, 2007 - 1:38pm
On 20 September 2007 the CHMP
(Committee for Medicinal Products for Human Use)
of the EMEA
(European Medicines Evaluation Agency) adopted a positive opinion towards Tasigna and recommended to grant a marketing...
Posted on Saturday, September 29, 2007 - 1:34pm
" Bristol-Myers Squibb is pleased about the approval of the 100mg once-daily stating dose of Sprycel for chronic phase patients..... The clinical data on the new starting dose demonstrate improved patient tolerability...
- ‹ previous
- 32 of 33
- next ›